FIELD: organic chemistry. SUBSTANCE: invention relates to derivatives of indolizine of the formula (I) where R1 - carboxyl, esterified carboxyl; R2 - hydrogen, lower alkyl, halogen; R3 - aryl or ar(lower)- -alkyl, (lower)alkylcarbamoyl, (lower)alkyl, (lower)alkyl- -arylcarbamoyl-(lower)alkyl; R11 - hydrogen, lower alkyl; A - lower alkylene possibly substituted with oxo-group, lower alkylene; Q - carbonyl, lower alkylene; R4, R5 - hydrogen, lower alkyl; y - bond, lower alkylene; Z - lower alkylene, lower alkenylene, -O-, ; R6 - hydrogen, lower alkyl, ar(lower)alkyl that can has a suitable substitute, and their pharmacologically acceptable salts. Compounds are synthesized by interaction of compounds of the formula (II) and (III) where W10 - acid residue. Compounds of the formula (I) can be used as inhibitors of testosterone-5α-reductase for prophylaxis and treatment of diseases mediated with this enzyme (alopecia, acne, prostatitis). EFFECT: improved method of synthesis. 13 cl, 6 dwg, 112 ex
Title |
Year |
Author |
Number |
1,2,3,4-TETRAHYDROPYRAZOLO-[5,1-C]-(1,2,4)-TRIAZINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION INHIBITING PRODUCING AN INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, METHOD OF PROPHYLACTIC OR THERAPEUTIC TREATMENT OF PATIENTS WITH DISEASES MEDIATED BY INTERLEUKIN AND TUMOR NECROSIS FACTOR |
1994 |
- Esio Kavai
- Khitosi Jamazaki
- Khirokazu Tanaka
- Teruo Oku
|
RU2124517C1 |
POLYPEPTIDE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND/OR THERAPEUTIC TREATMENT |
1994 |
- Khidenori Okhki
- Masaki Tomisima
- Akira Jamada
- Khisasi Takasugi
|
RU2164230C2 |
POLYPEPTIDE COMPOUND, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1995 |
- Khidenori Oki
- Masaki Tomisima
- Akira Jamada
- Khizasi Takazugi
|
RU2165423C2 |
GUANIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND METHOD FOR INHIBITING Na/H EXCHANGE IN CELLS |
1994 |
- Atsusi Kuno
- Josikazu Inou
- Khisasi Takasugi
- Khiroaki Mizuno
- Kumi Jamasaki
|
RU2141946C1 |
HETEROCYCLIC COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1994 |
- Teruo Oku
- Khirosi Kajakiri
- Sigeki Satokh
- Josito Abe
- Juki Savada
- Takajjuki Inoju
- Khirokazu Tanaka
|
RU2135478C1 |
HETEROBICYCLIC DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1995 |
- Norikhiko Simazaki
- Sinja Vatanabe
- Akikhiko Savada
- Kejdzi Khemmi
|
RU2170737C2 |
HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS |
1994 |
- Taniguti Kiesi
- Nagano Masanobu
- Khattori Kojudzi
- Tsubaki Kazunori
- Okitsu Osamu
- Tabuti Sejitiro
|
RU2176640C2 |
DERIVATIVES OF N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE AS ANTAGONISTS OF PLATELET ACTIVATION FACTOR, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1994 |
- Mitsuru Okhkubo
- Fumie Takakhasi
- Tosio Jamanaka
- Khiroesi Sakai
- Masajuki Kato
|
RU2161155C2 |
ETHANOLAMINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
1993 |
- Juiti Siokava
- Masanobu Nagano
- Kijosi Taniguti
- Kazukhiko Take
- Takesi Kato
- Kazunori Tsubaki
|
RU2125983C1 |
PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1993 |
- Masaaki Matsuo
- Kijosi Tsudzi
- Takasi Ogino
- Nobukijo Konisi
|
RU2128172C1 |